Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

23-OR: ADA Presidents’ Select Abstract: Genetic Architecture and Novel Genes Implicated in Youth-Onset Type 2 Diabetes.

  • Read more about 23-OR: ADA Presidents’ Select Abstract: Genetic Architecture and Novel Genes Implicated in Youth-Onset Type 2 Diabetes.

Low-Dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report.

  • Read more about Low-Dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report.

The First Genome-Wide Association Study for Type 2 Diabetes in Youth: The Progress in Diabetes Genetics in Youth (ProDiGY) Consortium.

  • Read more about The First Genome-Wide Association Study for Type 2 Diabetes in Youth: The Progress in Diabetes Genetics in Youth (ProDiGY) Consortium.

1360-P: Infertility Is Not Associated with Clinical Factors in Women with Type 1 Diabetes (T1D).

  • Read more about 1360-P: Infertility Is Not Associated with Clinical Factors in Women with Type 1 Diabetes (T1D).

988-P: Do-It-Yourself Artificial Pancreas Systems for Type 1 Diabetes Reduce Hyperglycemia without Increasing Hypoglycemia.

  • Read more about 988-P: Do-It-Yourself Artificial Pancreas Systems for Type 1 Diabetes Reduce Hyperglycemia without Increasing Hypoglycemia.

897-P: Real-World Response to Real-Time Continuous Glucose Monitoring by Caregivers of Children with Type 1 Diabetes.

  • Read more about 897-P: Real-World Response to Real-Time Continuous Glucose Monitoring by Caregivers of Children with Type 1 Diabetes.

942-P: Caregivers of Children with Type 1 Diabetes Value Real-Time Functions of Continuous Glucose Monitoring.

  • Read more about 942-P: Caregivers of Children with Type 1 Diabetes Value Real-Time Functions of Continuous Glucose Monitoring.

1355-P: HbA1c Trajectories from Time of Diagnosis in Youth with T1D.

  • Read more about 1355-P: HbA1c Trajectories from Time of Diagnosis in Youth with T1D.

Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data.

  • Read more about Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data.

Decreasing Incidence of Postinsulin Hypoglycemia for Hyperkalemia Treatment.

  • Read more about Decreasing Incidence of Postinsulin Hypoglycemia for Hyperkalemia Treatment.

Pagination

  • Previous page ‹‹
  • Page 3
  • Next page ››
Subscribe to Diabetes

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List